Sun-Young Hwang, Cheol-Jung Lee, Kwanhwan Wi, Young-Kwon Kim, Soo-Bin Nam, Ju Yeon Lee, Goo Yoon, Geul Bang, Jung-Hyun Shim, Mee-Hyun Lee
{"title":"Modulating the BI-1(TMBIM6)/AKT Signaling Pathway by Licochalcone D Treatment Inhibits Human Melanoma Cell Growth.","authors":"Sun-Young Hwang, Cheol-Jung Lee, Kwanhwan Wi, Young-Kwon Kim, Soo-Bin Nam, Ju Yeon Lee, Goo Yoon, Geul Bang, Jung-Hyun Shim, Mee-Hyun Lee","doi":"10.1002/ptr.70089","DOIUrl":null,"url":null,"abstract":"<p><p>Skin cancer is a common type of cancer worldwide with increasing incidence and mortality rates. Phytochemicals, active compounds from plants, are known to exhibit diverse physiological activities with benefits of low cytotoxicity and cost. In this study, we aimed to assess the effects of Licochalcone D (LicoD) derived from Glycyrrhiza inflata on human melanoma cell proliferation and investigate its new underlying mechanisms. To assess the anticancer effects of LicoD on melanoma cells, we conducted MTT and soft agar assay, flow cytometry analysis, Western blots as well as TPA-induced inflammatory mouse model and immunohistochemical analysis. To further uncover the new mechanisms, we assessed MS/MS-based proteomic analysis and verified by knockdown and proliferation assays. LicoD (2.5, 5, and 10 μΜ) dose-dependently inhibited cell growth, induced G2/M phase arrest of cell cycle, and triggered apoptosis in SK-MEL-5 and SK-MEL-28 cells together with regulating the related markers. Importantly, we newly discovered that LicoD suppressed the expression of Bax inhibitor (BI)-1(TMBIM6), an upstream regulator of AKT signaling pathway, as confirmed by informatic analysis and Western blotting. Moreover, we demonstrated by shRNA-mediated knockdown of BI-1(TMBIM6) in melanoma cells that BI-1 plays a critical role in cell proliferation and anchorage-independent growth. Rescue assays using BIA further confirmed the functional contribution of BI-1 to the effects of LicoD. In addition, topical treatment of LicoD reduced epidermal hyperplasia and the expression of pAKT, BI-1 and COX-2 in TPA-induced inflammatory skin tissues. Taken together, our findings provide novel evidences that LicoD exerts anti-melanoma effects by down-regulation of BI-1(TMBIM6)/AKT signaling pathways in vitro and in vivo. These findings suggest essential insights for the future development of strategies in skin cancer prevention and treatment.</p>","PeriodicalId":20110,"journal":{"name":"Phytotherapy Research","volume":" ","pages":""},"PeriodicalIF":6.3000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytotherapy Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ptr.70089","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Skin cancer is a common type of cancer worldwide with increasing incidence and mortality rates. Phytochemicals, active compounds from plants, are known to exhibit diverse physiological activities with benefits of low cytotoxicity and cost. In this study, we aimed to assess the effects of Licochalcone D (LicoD) derived from Glycyrrhiza inflata on human melanoma cell proliferation and investigate its new underlying mechanisms. To assess the anticancer effects of LicoD on melanoma cells, we conducted MTT and soft agar assay, flow cytometry analysis, Western blots as well as TPA-induced inflammatory mouse model and immunohistochemical analysis. To further uncover the new mechanisms, we assessed MS/MS-based proteomic analysis and verified by knockdown and proliferation assays. LicoD (2.5, 5, and 10 μΜ) dose-dependently inhibited cell growth, induced G2/M phase arrest of cell cycle, and triggered apoptosis in SK-MEL-5 and SK-MEL-28 cells together with regulating the related markers. Importantly, we newly discovered that LicoD suppressed the expression of Bax inhibitor (BI)-1(TMBIM6), an upstream regulator of AKT signaling pathway, as confirmed by informatic analysis and Western blotting. Moreover, we demonstrated by shRNA-mediated knockdown of BI-1(TMBIM6) in melanoma cells that BI-1 plays a critical role in cell proliferation and anchorage-independent growth. Rescue assays using BIA further confirmed the functional contribution of BI-1 to the effects of LicoD. In addition, topical treatment of LicoD reduced epidermal hyperplasia and the expression of pAKT, BI-1 and COX-2 in TPA-induced inflammatory skin tissues. Taken together, our findings provide novel evidences that LicoD exerts anti-melanoma effects by down-regulation of BI-1(TMBIM6)/AKT signaling pathways in vitro and in vivo. These findings suggest essential insights for the future development of strategies in skin cancer prevention and treatment.
期刊介绍:
Phytotherapy Research is an internationally recognized pharmacological journal that serves as a trailblazing resource for biochemists, pharmacologists, and toxicologists. We strive to disseminate groundbreaking research on medicinal plants, pushing the boundaries of knowledge and understanding in this field.
Our primary focus areas encompass pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine. We actively encourage submissions on the effects of commonly consumed food ingredients and standardized plant extracts. We welcome a range of contributions including original research papers, review articles, and letters.
By providing a platform for the latest developments and discoveries in phytotherapy, we aim to support the advancement of scientific knowledge and contribute to the improvement of modern medicine.